- ¥177bn
- ¥185bn
- ¥27bn
Catalyst Biosciences up on buying fibrosis drug candidate from GNI Group
9-MTH group results (IFRS)
6-MTH group results (IFRS)
Q1 group results (IFRS)
2021 group results (IFRS)
9-MTH group results (IFRS)
6-MTH group results (IFRS)
2021 group forecast(IFRS)
Q1 group results (IFRS)
2020 group results (IFRS)
2020 group results (IFRS)
2020 group results (IFRS)
2020 group results (IFRS)
9-MTH group results (IFRS)
Reuters Insider - The Libyan city split by a global proxy war
6-MTH group results (IFRS)
Q1 group results (IFRS)
2019 group results (IFRS)
2019 group results (IFRS)